# Recombinant DNA (genetic engineering): Overview

Source page: https://www.materialinsights.org/technologies/recombinant_dna/tech-overview/

#### What it does

The job the technology does for people, in a short paragraph

Recombinant DNA lets scientists move a gene from one organism into another, so that a host such as a bacterium or a cultured cell makes a protein it would not make on its own. The first experiments succeeded in 1973, and the first product, human insulin, was approved in 1982 ^[1]. The method now underlies many biological medicines and genetically modified crops ^[1].

as of 2026-11-11

#### How it works

The working principle in plain words, step by step

Every living thing stores its instructions in DNA, written in the same four-letter code. That shared code is what makes the method possible: a human gene placed in a bacterium is read by the bacterium's own machinery. Special enzymes, first found in bacteria, cut DNA at particular places, and the cut pieces from different sources can be joined ^[1]^[3]. The joined DNA is carried into a host cell, which copies it each time it divides ^[1]. The cells read the gene and make its protein. For a medicine, the protein is then purified in licensed plants and each product is approved by regulators before use.

as of 2026-11-11

#### Key figures

The handful of numbers that size it up, each with its unit, year and source

| Figure | Value | Unit | Year | Source |
|---|---|---|---|---|
| People with type 2 diabetes who rely on insulin, more than | 60 | million people | 2021 | ^[5] |
| People with type 1 diabetes for whom insulin makes the disease manageable | 9 | million people | 2021 | ^[5] |
| Share of the insulin market held by three multinational companies, more than | 90 | % | 2021 | ^[5] |
| Possible saving from biosimilar insulins, more than | 25 | % | 2021 | ^[5] |

as of 2026-11-11. Insulin, the first recombinant medicine, is used as the clearest measure of reach; no world figure for all recombinant products was found.

#### Where it is used

The main places and products the technology is found in

- Medicines such as human insulin, growth hormone and many vaccines and antibodies
- Enzymes for food, detergents and industry
- Genetically modified crops
- Basic research in biology and medicine
- Gene therapy and gene editing research

as of 2026-11-11

#### Scale today

How much of it there is now: units in use, made each year and who uses it

**Users**
: More than 60 million people with type 2 diabetes and about 9 million with type 1 depend on insulin ^[5]

**Unit**
: people

**Year**
: 2021

**Note**
: Counts insulin users only, as a guide; no world count of all recombinant products was found.

as of 2026-11-11

#### Sources

1. [Herbert W. Boyer and Stanley N. Cohen](https://www.sciencehistory.org/education/scientific-biographies/herbert-w-boyer-and-stanley-n-cohen/) Science History Institute
2. [The Nobel Prize in Physiology or Medicine 1978: summary](https://nobelprize.org/prizes/medicine/1978/summary) Nobel Prize Outreach (nobelprize.org)
3. [New WHO report maps barriers to insulin availability and suggests actions to promote universal access](https://www.who.int/news/item/12-11-2021-new-who-report-maps-barriers-to-insulin-availability-and-suggests-actions-to-promote-universal-access) World Health Organization, 2021

## Other sections

- [Summary](https://www.materialinsights.org/technologies/recombinant_dna/index.md)
- [Science](https://www.materialinsights.org/technologies/recombinant_dna/tech-science/index.md)
- [Evolution](https://www.materialinsights.org/technologies/recombinant_dna/tech-evolution/index.md)
- [Materials](https://www.materialinsights.org/technologies/recombinant_dna/tech-materials/index.md)
- [Energy footprint](https://www.materialinsights.org/technologies/recombinant_dna/tech-energy-footprint/index.md)
- [Industries](https://www.materialinsights.org/technologies/recombinant_dna/tech-industries/index.md)
